Release Date: 12/11/13 09:10 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 20.66KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%